INVO

INVO Bioscience, Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website invobio.com
Employees(FY) 15
ISIN US44984F4019

Performance

+8.06%

1W

+29.61%

1M

+12.19%

3M

-48.43%

6M

-27.04%

YTD

-86.39%

1Y

Profile

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.

Advanced Technical Analysis

Technical Analysis of INVO 2024-05-10

Overview:

In analyzing the technical indicators for INVO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key factors, we aim to offer valuable insights and recommendations for potential in...

See more ...

Recent News & Updates

2024-05-15 09:53
INVO Stock Earnings: INVO Bioscience Reported Results for Q1 2024(Investorplace)
2024-05-15 04:15
INVO Reports Record First Quarter 2024 Financial Results(Globenewswire)
2024-05-13 19:34
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday(Investorplace)
2024-04-16 20:16
Why Is Invo Bioscience (INVO) Stock Up 85% Today?(Investorplace)
2024-04-16 09:53
INVO Stock Earnings: INVO Bioscience Reported Results for Q4 2023(Investorplace)
2024-04-16 04:59
INVO Reports Fourth Quarter and Full Year 2023 Financial Results(Globenewswire)
2024-01-22 19:00
NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)(Globenewswire)
2024-01-16 19:00
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors(Globenewswire)
2023-12-10 19:00
NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK Bispecific Antibody in the American Society of Hematology's Blood Journal(Prnewswire)
2023-12-05 20:00
NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies(Prnewswire)
2023-11-27 20:00
INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement(Prnewswire)
2023-11-13 03:01
INVO Reports Record Third Quarter 2023 Financial Results(Prnewswire)
2023-11-12 19:15
BestGrowthStocks.Com Issues Comprehensive Analysis Regarding INVO Biosciences Merger(Yahoo Finance)
2023-11-09 20:00
NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger(Prnewswire)
2023-11-09 03:40
INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants(Prnewswire)
2023-10-26 21:00
Free Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event "Accelerating Biotech Value Creation" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023(Yahoo Finance)
2023-10-23 22:08
Moore Kuehn Encourages INVO, ESMT, HES, and TGH Investors to Contact Law Firm(Globenewswire)
2023-10-23 20:45
Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments(Prnewswire)
2023-10-23 01:40
Why Is INVO Bioscience (INVO) Stock Up 325% Today?(Investorplace)
2023-10-22 19:30
INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company(Prnewswire)
2023-10-10 21:00
INVO to Participate in the Lytham Partners Fall 2023 Investor Conference(Prnewswire)
2023-09-29 04:05
INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS(Prnewswire)
2023-09-28 00:30
INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET(Prnewswire)
2023-08-14 04:05
INVO Reports Second Quarter 2023 Financial Results(Yahoo Finance)
2023-08-10 20:00
INVO Closes Acquisition of Wisconsin Fertility Institute(Yahoo Finance)
2023-08-09 04:15
INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023(Yahoo Finance)
2023-08-08 01:55
INVO Bioscience Announces Closing of $4.5 Million Public Offering(Yahoo Finance)
2023-08-03 21:00
INVO Bioscience Announces Pricing of $4.5 Million Public Offering(Yahoo Finance)
2023-08-02 20:00
INVO Sets Revised Closing Date of Wisconsin Fertility Institute Acquisition and Announces Key Operational Trends to Drive Shareholder Value(Yahoo Finance)
2023-07-26 21:26
INVO Announces a 1:20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023(Yahoo Finance)

Page 1 of 4

previousnext